DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Systemic lupus erythematosus	R-HSA-977105	map05322	oxaprozin	4614	drug-path
Asthma	R-HSA-444620	map05310	oxaprozin	4614	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	oxaprozin	4614	drug-path
Allograft rejection	R-HSA-9679028	map05330	oxaprozin	4614	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	oxaprozin	4614	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	oxaprozin	4614	drug-path
Axon guidance	R-HSA-422475	map04360	oxaprozin	4614	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	oxaprozin	4614	drug-path
SNARE interactions in vesicular transport	R-HSA-428625	map04130	5230742	None	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	5230742	None	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	5230742	None	drug-path
Basal transcription factors	R-HSA-3232118	map03022	5230742	None	drug-path
Shigellosis	0	map05131	ikarugamycin	54680304	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	ikarugamycin	54680304	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ikarugamycin	54680304	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	ikarugamycin	54680304	drug-path
SNARE interactions in vesicular transport	R-HSA-428625	map04130	quinostatin	522325	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	quinostatin	522325	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	quinostatin	522325	drug-path
Olfactory transduction	R-HSA-9751605	map04740	quinostatin	522325	drug-path